Allium Ltd

Looking to expand your medical device portfolio in Spain? 🩺💼 Frequent stent replacements strain both hospitals and patients. Allium’s self-expanding metallic stent changes the game: 1 placement lasts up to 3 years—CE-approved for long-term indwelling. Why partner with Allium? 🔹 High Demand: Reduces procedure costs and re-interventions for hospitals. 🔹 Unique Value: Full patency, superior patient comfort, and zero tissue ingrowth. 🔹 Easy Removal: Fully retrievable at any time with alligator/rat tooth forceps in a short and easy procedure (given proper patient follow-up and following tips & tricks) Bring the longest-indwelling urological stent to your territory and build a strong, recurring business.

Looking to expand your medical device portfolio in Spain? 🩺💼 Ureteric fistulas are a major clinical challenge—and a huge market opportunity for distributors and sales reps. Allium’s self-expandable URS stent delivers proven results: ✅ 91% cure rate for small fistulas (6 months) ✅ 79% cure rate for complete defects up to 5cm (1 year) ✅ The ONLY CE-approved stent for fistula treatment & up to 3 years indwelling time Partner with Allium to bring this unique solution to urologists in your region and drive new revenue streams.

Surgical-level cure rates. Minimally invasive. The Allium Ureteral Stent offers a groundbreaking approach to ureteric fistulas — with clinical outcomes comparable to surgery: 91% cure rate for small fistulas within 6 months, and 79% cure for complete defects within just one year. Eliminating in some cases the need for reconstructive surgery through stent bridging — without invasive intervention Meet us at EAU26 London | Booth Q28 ExCeL London | 13–16 March Hands-on model practice available at our booth during the event Click below to learn more and schedule a meeting in person! or drop us an email here: [email protected]

Stop the cycle of repeated Double-J stent replacements. The Allium Ureteral Fully-Covered Stent is a minimally invasive, long-term solution for urological strictures and fistulas, offering proven effectiveness, immediate relief of symptoms, full-patency along the entire indwelling time and a dramatically improved quality of life for the patient with fewer to none repeat procedures (depends if cured or not in benign cases). Meet us at EAU26 London | Booth Q28 ExCeL London | 13–16 March Interested in scheduling a meeting at our booth? Click below!

80% of benign strictures were cured within one year. The Allium Fully-Covered Stent is redefining how we approach ureteric and urethral strictures — not just managing symptoms, but achieving actual cure in the majority of cases, backed by 8 distinct clinical studies and with 1-6 years post stent removal follow-up. A curative solution. Not just another intervention. Curative effect is yet to recieve CE Meet us at EAU26 London | Booth Q28 ExCeL London | 13–16 March Hands-on model practice available at our booth during the event Click below to book a meeting

Surgical-level cure rates. Minimally invasive. The Allium Ureteral Stent offers a groundbreaking approach to ureteric fistulas — with clinical outcomes comparable to surgery: 91% cure rate for small fistulas within 6 months, and 79% cure for complete defects within just one year. Eliminating in some cases the need for reconstructive surgery through stent bridging — without invasive intervention Meet us at EAU26 London | Booth Q28 ExCeL London | 13–16 March Hands-on model practice available at our booth during the event